Furthermore, our results revealed that silencing STAT3 in anti-Act1 macrophages markedly inhibited CRC cells-induced CXCL10 and PD-L1 expression in anti-Act1 macrophages (Fig. 5A (b)). Here, TRAF3IP2 is linked to colorectal carcinoma.